PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who can speak and understand English
- People who are able to give informed consent to participate
- People who are currently held in one of the prisons that have partnered with this study
- People who met the criteria for a drug use disorder in the year before their current time in prison (meaning at least 2 symptoms on a standard drug use disorder checklist)
- People who used drugs in the 30 days before their current time in prison
- People who have been exposed to at least one traumatic event in their life
- People who are currently experiencing significant post-traumatic stress symptoms, as measured by a standard screening tool (confirm with trial site for exact score requirements)
- People who are expected to remain in prison long enough to complete the full treatment program, which is approximately 3 months (the exact timeframe depends on the schedule at each site)
- People who are expected to be released from prison within 12 months after finishing the treatment program
- People who agree to be randomly assigned to a treatment group
Who may not be able to join:
- People who are unable to provide any contact or location information for follow-up assessments after release
- People who are expected to be released before there would be enough time to complete the treatment program
- People who have a scheduling conflict or a prison restriction — such as a disciplinary or medical matter — that would prevent them from taking part in the treatment program (though in some cases, a person may be placed on a waiting list for the next available group rather than being removed from the study entirely, depending on the circumstances)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melissa J Zielinski, PhD, University of Arkansas
Phone: 501-526-8229
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Drug Use Frequency (Count); Drug use (Binary); Posttraumatic Stress Symptom Severity (Sum); Treatment fidelity (ratio)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.